Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Alkagin Paste in the Prevention of Radiation Dermatitis

This study has been terminated.
Avario Healthcare Inc.
Information provided by (Responsible Party):
Dr. Te Vuong, Sir Mortimer B. Davis - Jewish General Hospital Identifier:
First received: August 2, 2011
Last updated: May 22, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)